Clinical Trial Update: Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors

View source ↗

Summary

Clinical trial update indicating that temozolomide may cause changes in semen or sperm in patients with primary malignant brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Brain Tumor

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Central Nervous System Tumors, Chemotherapeutic Agent Toxicity | Status: COMPLETED